RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
149 hedge funds and large institutions have $1.53B invested in Revance Therapeutics, Inc. in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 58 increasing their positions, 50 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
6% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 17
1% less funds holding
Funds holding: 151 → 149 (-2)
Holders
149
Holding in Top 10
2
Calls
$9.56M
Puts
$9.03M
Top Buyers
| 1 | +$17.2M | |
| 2 | +$14.8M | |
| 3 | +$12.3M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$10.7M |
| 5 |
BlackRock
New York
|
+$10.7M |
Top Sellers
| 1 | -$16.3M | |
| 2 | -$13.8M | |
| 3 | -$12.1M | |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$6.06M |
| 5 |
OCM
Osterweis Capital Management
San Francisco,
California
|
-$4.96M |